The question in many minds after hearing of the DePuy ASR hip replacement recall is Why did DePuy continue selling the devices in America two years after pulling them from the Australian market for defective parts and materials? That is a question DePuy will have to answer in court. Many people who experienced problems with their hip implants before the devices were recalled in August 2010 didn’t even know the problems were due to the implant itself.
Hundreds of lawsuits against the company claim that they should have pulled the devices from the market years earlier when reports of device failure began mounting. A lawsuit was also filed on behalf of 13 patients from Illinois and Indiana, all of whom required second surgeries to have DePuy ASR hip replacement implants removed.
The lawsuit alleges that DePuy should have issued a recall when the company discovered issues with the metal-on-metal designs; however, DePuy did not properly test the devices before they were issued for use in patients.
A Louisiana Record article reports on a Georgia resident who has filed a lawsuit in a New Orleans Federal Court against DePuy and parent company Johnson & Johnson over the defective hip replacement devices. The plaintiff claims that his hip replacement surgery went extremely well, but that “he experienced pain and extreme weakness in his hip and quadriceps despite ideal conditions for the hip replacement,” the article said.
DePuy is accused, in many lawsuits filed around the country, of failing to warn of the high rate of failures of its ASR cups, negligently designing, manufacturing, labeling and distribution of the device, strict liability for defective product, breach of implied and express warranty,” the article continued.
Massey, Michelle. (October 12, 2010) “Lawsuit alleges Depuy hip replacement device is defective.” Retrieved on October 21, 2010 from the Louisiana Record.
When a drug or a medical device gets recalled for malfunctioning or endangering the health and lives of patients, it can profoundly affect the lives of the individuals involved. That is certainly the case with the nearly 100,000 patients around the world who received the DePuy ASR hip replacement implants. DePuy issued a recall of their products in August 2010, leaving many patients still wondering what to do next. Read more
Hip implants require serious surgery. Patients who undergo the hip replacement surgery do so with the understanding that the implants will remain functional for approximately 15 years. The recalled DePuy ASR hip replacement systems began to fail in less than five years for at least 13% of the patients who had them implanted. Read more
The DePuy ASR hip replacement device recall saga that began in August 2010 continues to present frustrating challenges to patients who have the device implanted and are wondering what to do next. Studies and hospital reports have demonstrated a 13% failure rate on the devices. Over 93,000 patients around the world have the devices implanted, which means about 12,000 people will likely face a second surgery to remove and replace the devices, a Burnt Orange Report article notes. Read more
Over a dozen individual and class action lawsuits have been filed in federal and state courts across America over DePuy’s defective recalled hip replacement systems. Lawyers for the plaintiffs filed a motion in September 2010 to consolidate the lawsuits into a multidistrict litigation in a New Jersey Federal Court. Depuy attorneys filed an objection to the motion, preferring to stage the trials closer to company headquarters in Indiana, a Wisconsin Law Journal website reports. Read more
As the DePuy Orthopedics hip recall lawsuits continue to mount, concern is being raised over metal toxicity from the metal on metal parts of the implants. A San Francisco Gate article notes that many patients who received the implants are now or have the potential to suffer symptoms of metal poisoning. Read more
In the recent tempest of news swirling around DePuy Orthopedics, Inc’s hip replacement recall, most media outlets have overlooked an FDA warning letter issued only days before the DePuy Hip Recalls began. The letter was sent on August 19, 2010 from FDA representative Timothy A. Ulatowski to David Floyd, president of DePuy Orthopedics, Inc. Read more
The recent flurry of news concerning the DePuy ASR Recall has gotten the attention of more than just DePuy Hip Lawyers and patients who have had the recalled devices implanted. A recent release published by PR Canada reported on quality hip and joint replacements from the Krauss Center for Join Replacement. Read more
The U.K. Newspaper, the Independent, recently reported on the DePuy Hip Recalls that have tens of thousands of patients reporting back to the hospitals where they received the implants to have them checked for safety and potential dangers involved with the devices. Read more
The August 2010 voluntary Depuy ASR Recall and subsequent Depuy Hip Class Action Lawsuit cases have revealed more problems than patients might suspect. Johnson & Johnson seems to be facing a never ending onslaught of product recalls, factory closures, lawsuits, and media scrutiny over quality control in multiple divisions. Read more